[Form 4] HARTFORD INSURANCE GROUP, INC. Insider Trading Activity

Rhea-AI Filing Summary

Hartford Insurance Group, Inc.'s president reported an option exercise and share sale. On 11/26/2025, he exercised a stock option for 6,731 shares of common stock at an exercise price of $48.89 per share, increasing his directly held shares. That same day, he sold 6,731 shares of common stock at a price of $137.90 per share, leaving a direct holding of 31,721.067 shares after the transactions.

The filing also lists multiple outstanding stock option grants with exercise prices ranging from $49.01 to $116.41 and expirations between 2027 and 2035. The transactions were carried out under a previously adopted Rule 10b5-1 trading plan dated August 25, 2025.

Insider Trade Summary

Net Seller: 6,731 shares ($928,205)

Net Sell 11 txns

Insider TOOKER ADIN M

Role President

Sold 6,731 shs ($928K)

Type	Security	Shares	Price	Value
Exercise	Stock Option	6,731	$0.00	--
Exercise	Common Stock	6,731	$48.89	$329K
Sale	Common Stock	6,731	$137.90	$928K
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 0 shares (Direct); Common Stock — 38,452.067 shares (Direct)

Footnotes (1)

1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOOKER ADIN M

(Last) (First) (Middle)

ONE HARTFORD PLAZA

(Street)

HARTFORD CT 06155

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTFORD INSURANCE GROUP, INC. [ HIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		M		6,731	A	$48.89	38,452.067	D
Common Stock	11/26/2025		S(1)		6,731	D	$137.9	31,721.067	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$48.89	11/26/2025		M			6,731	(2)	02/28/2027	Common Stock	6,731	$0.0000	0.0000	D
Stock Option	$49.01							(3)	02/26/2029	Common Stock	26,687		26,687	D
Stock Option	$51.87							(4)	02/23/2031	Common Stock	25,202		25,202	D
Stock Option	$53.81							(5)	02/27/2028	Common Stock	16,614		16,614	D
Stock Option	$55.27							(6)	02/25/2030	Common Stock	24,094		24,094	D
Stock Option	$69.41							(7)	02/23/2032	Common Stock	24,155		24,155	D
Stock Option	$78.28							(8)	02/28/2033	Common Stock	24,301		24,301	D
Stock Option	$95.74							(9)	02/27/2034	Common Stock	16,492		16,492	D
Stock Option	$116.41							(10)	02/25/2035	Common Stock	25,488		25,488	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

2. The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.

3. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.

4. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.

5. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.

6. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.

7. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.

8. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.

9. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.

10. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

	Anthony J. Salerno, Jr., Attorney-in-Fact	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.